Results 81 to 90 of about 1,117 (151)

An Interactive Pharmacokinetic-Pharmacodynamic Framework to Evaluate Bedaquiline Dose Modifications in Adults With Tuberculosis. [PDF]

CPT Pharmacometrics Syst Pharmacol
Lin YJ, Okibedi F, Karlsson MO, Svensson EM.   +3 more
europepmc   +1 more source

Exposure-QTc modeling of bedaquiline, pretomanid, and clofazimine in adults with tuberculosis. [PDF]

Antimicrob Agents Chemother
Abdelwahab MT, Svensson EM, Diacon AH, Conradie A, Olugbosi M, Dawson R, Maartens G, Denti P.   +7 more
europepmc   +1 more source

The quantity and severity of adverse drug reactions experienced by patients with multi-drug resistant tuberculosis in the Ugu District. [PDF]

BMC Infect Dis
Ramasir S, Oosthuizen F, Bangalee V.
europepmc   +1 more source

Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease.

Chest, 2015
J. Philley, R. Wallace, Jeana L. Benwill, Varsha Taskar, B. Brown-Elliott, Foram A. Thakkar, T. Aksamit, D. Griffith   +7 more
semanticscholar   +1 more source

Incidence of QT interval prolongation in patients receiving bedaquiline for drug-resistant tuberculosis in Sub-Saharan Africa: a protocol for systematic review and meta-analysis. [PDF]

BMJ Open
Okello-Obol M, Pitua I, Okema JN, Ekwem D, Bongomin F, Olum R.   +5 more
europepmc   +1 more source

Efficacies of Sequenced Monotherapies of Mycobacterium avium Lung Infection in Mouse. [PDF]

J Infect Dis
Howe RA, Rimal B, Khandelwal J, Panthi CM, Lamichhane G.   +4 more
europepmc   +1 more source

Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective study. [PDF]

Lancet Microbe
Steyn J, Williams J, Naufal F, Limberis J, Grobbelaar M, Ismail N, Ghebrekristos Y, Opperman CJ, Nalyvayko A, Singh S, Colman RE, Rodwell TC, Theron G, Warren RM, Metcalfe JZ.   +14 more
europepmc   +1 more source

Bedaquiline inhibits the ATP synthase leak channel and prevents glutamate-induced neuronal death. [PDF]

Biophys Rep (N Y)
Kumar A, Lunko O, Smith E, Mezghani I, Eedarapalli S, Wu Y, Ferdous KA, Amjad E, Park HA, Mnatsakanyan N.   +9 more
europepmc   +1 more source

Evaluation of clofazimine-bedaquiline combination as a candidate regimen for macrolide-resistant <i>Mycobacterium avium</i> complex infection. [PDF]

Antimicrob Agents Chemother
Park J, Choi S, Jeon YR, Kim L-H, Lee JM, Shin SJ.   +5 more
europepmc   +1 more source

Bedaquiline combined with clofazimine as salvage therapy for 11 patients with nontuberculous mycobacterial lung disease. [PDF]

BMC Infect Dis
Yao L, He Y, Yang J, Zheng X, Shi X, Wei W, Yang G, Ying R, Sha W.   +8 more
europepmc   +1 more source